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Abstract 
The controlled release of nucleic acids from cationic polymers is an important criteria for the 
design of gene delivery systems, and can be difficult to achieve due to the persistent positive 
charges required to initially complex the nucleic acids. Here, we report the use of highly 
branched tertiary amine-rich polymers for the complexation and release of dsRNA over a 
prolonged period of time. Controlled release of dsRNA is obtained via hydrolysis of the 
polymer side chains and associated change in electrostatic charge. Reversible addition-
fragmentation chain transfer (RAFT) polymerization was utilised to synthesise a series of 
branched polymers of 2-(dimethylamino)ethyl acrylate (DMAEA), 3-(dimethylamino)propyl 
acrylate (DMAPA), and 2-(dimethylamino)ethyl methacrylate (DMAEMA) (MW ~ 60,000 – 
200,000 g/mol, and Ð ~ 2 – 8) and copolymers thereof. The hydrolysis kinetics of all 
synthesised polymer materials were followed by 1H NMR spectroscopy. Complexation with 
dsRNA resulted in the formation of polyplex nanoparticles (N/P ratio of 5) with sizes of 
approximately 400 nm and surface charges of +15 mV. An agarose gel release study showed 
sustained release of dsRNA from p(DMAEA-co-DMAEMA) for a period of more than 2 
weeks. Unlike branched PEI commonly used for gene delivery, the majority of these systems 
showed little toxicity to cells (NIH3T3 fibroblasts). The results point towards pDMAPA and 
p(DMAEA-co-DMAEMA) being promising polymers for the controlled release of 
oligonucleotides over prolonged periods. 
 
Introduction 
Synthetic vectors that can be utilised to activate the RNA interference pathway, or transcribe 
for new proteins, by delivering nucleic acids (dsRNA, siRNA, mRNA, DNA) in target cells 
are gaining significant attention due to a number of potential advantages over viral vectors.1 
Particular benefits of synthetic vectors over viral vectors include: low immunogenicity,2 high 
nucleotide loading,3 as well as ease and reproducibility of production.4 Yet, there are many 
barriers associated with gene-based therapies, which at the moment limit greatly the number of 
products successfully passing through clinical trials. These include degradation of nucleic acids 
by nucleases in physiological fluids as well as the short half-life of naked plasmid DNA in vivo, 
which was estimated to be in the region of 10 minutes post systemic injection.1, 5 Synthetic 
vectors partly mediate these limitations by protecting nucleotides from enzymatic degradation, 
whilst also avoiding renal clearance and non-specific interactions with serum proteins and 
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extracellular compounds. In addition, synthetic vehicles need to extravasate from the 
vasculature, promote cell internalisation of otherwise negatively charged non-endocytosable 
nucleic acid biomolecules, and finally release the therapeutic nucleic acid in the intracellular 
environment. The latter is increasingly identified as a difficult hurdle to overcome as the strong 
electrostatic interactions between cationic synthetic systems and negatively charged 
oligonucleotides make it difficult to release the therapeutic cargo, dramatically decreasing the 
transfection yields.6-8  
Thanks to advances in polymer and materials chemistry, stimuli responsive gene delivery 
systems have made significant progress in the last few years.9, 10 These systems are able to 
respond to various stimuli and either trigger release of the transported nucleic acid, or promote 
endosomal escape of the carrier to the cell cytoplasm.11 Examples of endogenous stimuli 
include: intracellular changes in pH environment,12 change in redox environment,13 
temperature difference,14 or the presence of enzymatic triggers;15 while exogenous stimuli 
include: light,16 ultrasound,17 or even magnetism.18  
A major shortcoming of these stimuli-responsive systems lies in the toxicity of the cationic 
polymers remaining after the oligonucleotide release. In response, increasing attention is being 
directed towards developing degradable or charge altering polymers with biocompatible by-
products. Degradability can either be introduced in the polymer backbone, or through 
degradable polymer side chains. In the early 2000’s, the Langer group prepared poly(-amino 
esters) via Michael addition step growth polymerisation of diamines and diacrylates, resulting 
in cationic polymers with a degradable backbones and cationic groups for DNA 
complexation.19, 20 In another example,  Saltzman et al. encapsulated genetic material in 
poly(lactic-co-glycolic acid) (PLGA) to deliver siRNA efficiently through cervical mucus 
barrier in mice models.21 Backbone degradable polymers based on oligo(carbonate-b--amino 
ester)s were also shown to be efficient gene delivery vectors.22 Introduction of polymer 
degradability through the polymer side chains, leading to biocompatible and non-toxic 
degradation products, has also been studied extensively by the group of Hennink among 
others.23-25 The degradable side chain route however also has the added advantage of being 
able to incorporate a change in functionality and/or charge with side chain degradation. For 
example, polymers synthesised from 2-(dimethylamino)ethyl acrylate (DMAEA) have been 
investigated for the complexation and release of nucleic acids via hydrolysis of the ester 
connection between acrylate backbone and side chains.26-28 Poly(DMAEA) proved to be an 
attractive polymer for non-viral gene delivery whose initial structure combines hydrolysable 
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side chains with cationic groups. Upon hydrolysis, cationic side chains turn into negatively 
charged acrylic acid moieties which enhance nucleic acid release via electrostatic repulsion. 
The self-catalysed hydrolysis of pDMAEA in water was initially reported to reach a limiting 
degree of hydrolysis of  60 to 70 % after one week in aqueous conditions at room temperature.29 
More recent studies confirmed that the hydrolysis and nucleic acid release occurs rapidly (1 to 
10 hours28), and is consistent with a self-catalysed mechanism at a rate that is independent of 
pH, salt concentration, or any other external stimulus.27, 30-32 A number of strategies have been 
employed to lengthen this release time, but it is yet to be extended past 72 hours.33, 34  
Sustained release of nucleic acids for inducing RNA interference is acknowledged as a major 
challenge for the gene therapy field.35-37 Here, we report prolonged protection and sustained 
release of dsRNA from synthetic polymers prepared via reversible addition-fragmentation 
chain transfer (RAFT) polymerisation. Highly branched polymers of 2-(dimethylamino)ethyl 
acrylate (DMAEA), 3-(dimethylamino)propyl acrylate (DMAPA), 2-(dimethylamino)ethyl 
methacrylate (DMAEMA), and also statistical copolymers of DMAEA and DMAEMA were 
synthesised using di(ethylene glycol) diacrylate  (DEGDA) or ethyleneglycol dimethacrylate 
(EGDMA) as cross-linkers. We attempted two different synthetic routes in order to slow the 
side chain hydrolysis of tertiary amine containing polymers. Firstly, by polymerising DMAPA, 
a monomer with a propyl chain rather than the ethyl of DMAEA. Secondly, by copolymerising 
DMAEA with DMAEMA, a non-hydrolysing equivalent monomer.38 The branched polymers 
were characterized using multi-detector size exclusion chromatography (SEC) and their 
hydrolysis kinetics were followed with 1H NMR spectroscopy. Polyplex formation and dsRNA 
release was then investigated using agarose gel electrophoresis. Finally, polymer cytotoxicity 
was determined before and after side chain hydrolysis in relation to a model fibroblast cell line.  
 
Experimental 
Materials 
2-(dimethylamino)ethyl acrylate (DMAEA), 2-(dimethylamino)ethyl methacrylate 
(DMAEMA), 3-(dimethylamino)propyl acrylate (DMAPA), ethyleneglycol dimethacrylate 
(EGDMA), di(ethylene glycol) diacrylate (DEGDA), 4,4′-Azobis(4-cyanovaleric acid) 
(ACVA), 1,1′-Azobis(cyclohexanecarbonitrile) (VA088), polyethylenimine branched (bPEI, 
Mw ~25,000 by LS, Mn ~10,000 by SEC), Agarose, Ethidium bromide solution (500 μg/mL 
in H2O), were all obtained from Sigma-Aldrich. All other materials were purchased from Fisher 
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Scientific, or Sigma-Aldrich. dsRNA was provided by Syngenta. 2-(((butylthio)-
carbonothioyl)thio)propanoic acid (PABTC) was prepared according to a previously reported 
procedure.39 (4-cyano pentanoic acid)yl ethyl trithiocarbonate (CPAETC) was prepared 
according to a previously reported procedure.40 50X Tris-Acetate-EDTA (TAE) buffer for gel 
electrophoresis was made up at concentration of 2.0M Tris acetate (Sigma Aldrich) and 0.05M 
EDTA (Sigma Aldrich) in deionised water, pH 8.2 - 8.4, stored at room temperature. Gel 
loading buffer for samples (colourless) was made up at 30% (vol/vol) glycerol (Sigma Aldrich) 
in deionised water and stored at room temperature. 2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-
2H-tetrazolium-5-carboxanilide inner salt (XTT sodium salt), and Phenazine methosulfate 
(PMS) were obtained from Sigma. 
Characterisation 
Size Exclusion Chromatography (SEC) was performed in CHCl3, using an Agilent 390-LC 
MDS instrument equipped with differential refractive index (DRI), viscometry, dual angle light 
scattering, and dual wavelength UV detectors. The system was equipped with 2 x PLgel Mixed 
D columns (300 x 7.5 mm) and a PLgel 5 µm guard column. The eluent was CHCl3 with 2% 
TEA (trimethylamine) additive, and samples were run at 1 mL/min at 30 °C. Analyte samples 
were filtered through a nylon membrane with 0.22 μm pore size before injection. Apparent 
molar mass values (Mn,SEC and Mw,SEC) and dispersity (Đ) of synthesized polymers were 
determined by DRI detector and conventional polystyrene (Agilent EasyVials) calibration and 
using Agilent SEC software. The absolute/true molecular weight (Mw,MALLS) and the intrinsic 
viscosity (IV) were determined by triple-detection SEC method using Agilent software and 
considering 100% polymer mass recovery (knowing the concentration). The Kuhn-Mark-
Houwink-Sakurada parameter , relating to polymer conformation in solution was determined 
from the gradient of the double logarithmic plot of intrinsic viscosity as a function of molecular 
weight, using Agilent SEC software. Proton nuclear magnetic resonance spectra (1H NMR) 
were recorded on a Bruker Advance 400 or 300 spectrometer (400 MHz or 300 MHz) at 27 °C, 
with chemical shift values (δ) reported in ppm, and the residual proton signal of the solvent 
used as internal standard. Proton-decoupled carbon nuclear magnetic resonance spectra (13C 
NMR) were recorded on a Bruker Advance 400 (100 MHz) at 27 °C in CDCl3, with chemical 
shift values (δ) reported in ppm, and the residual proton signal of the solvent used as internal 
standard (δC 77.16). Fourier transform infrared spectra (FTIR) were recorded on a Bruker 
Alpha FTIR ATR. 
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Synthesis of branched acrylates pDMAEA and pDMAPA 
Conditions for polymerisations can be found in Supporting Information. For a typical 
polymerisation in which [M]: [DEGDA]: [PABTC]: [I] = 50: 2.5: 1: 0.1, PABTC (33.3 mg, 
0.140 mmol), DMAEA (1 g, 6.98 mmol), DEGDA (74.8 mg, 0.35 mmol), ACVA (3.9 mg, 
0.0140 mmol), and dioxane (1.19 mL) were added to a vial deoxygenated by bubbling with 
nitrogen and left to stir in an oil bath at 70 °C. After a predetermined time, the solution was 
removed from the oil bath and the polymer precipitated in hexane (x3), and dried under 
vacuum. Mw,MALLS = 299,000 g/mol, Ð,RI = 14 (CHCl3 SEC, multi-detector). 
1H NMR spectrum 
(400 MHz, CDCl3, δ ppm): 4.15 (m, 2H, -C(O)O-CH2-CH2-NMe2), 2.55 (m, 2H, -C(O)O-CH2-
CH2-NMe2), 2.27 (m, 6H, -CH2-NMe2), 2.11−0.91 (m, 3H, backbone). 13C NMR spectrum 
(100 MHz, CDCl3, δ ppm): 174.28 (-C(O)O-), 62.33 (-C(O)O-CH2-CH2-), 57.52 (-CH2-
N(CH3)2), 45.71 (-N(CH3)2), 41.28 (backbone tertiary), 25.02 (backbone -CH2-). FTIR cm-
1: 2948 (medium, C-H alkane), 2821 and 2768 (medium, N-CH3 amine), 1728 (strong, C=O 
ester), 1455 (medium, C-H alkane), 1251 (medium, C-N, amine), 1153 (strong, C-O ester). 
Synthesis of branched methacrylate pDMAEMA  
For a typical polymerisation in which [M]: [EGDMA]: [CPAETC]: [I] = 50: 0.95: 1: 0.025, 
CPAETC (33.5 mg, 0.127 mmol), DMAEMA (1 g, 6.36 mmol), EGDMA (24.0 mg, 0.121 
mmol), VA-088 (0.777 mg, 0.00318 mmol),  and dioxane (0.974 mL) were added to a vial 
deoxygenated by bubbling with nitrogen and left to stir in an oil bath at 90 °C. After a 
predetermined time, the solution was removed from the oil bath and the polymer precipitated 
in hexane (x3), and dried under vacuum. Mw,MALLS = 275,000 g/mol, Ð,RI = 8.2 (CHCl3 SEC, 
multi-detector). 1H NMR spectrum (400 MHz, CDCl3, δ ppm): 4.07 (m, 2H, -C(O)O-CH2-
CH2-NMe2), 2.57 (m, 2H, -C(O)O-CH2-CH2-NMe2), 2.29 (m, 6H, -CH2-NMe2), 2.17−0.74 (m, 
5H, backbone). 13C NMR spectrum (100 MHz, CDCl3, δ ppm): 177.36 (-C(O)O-), 63.03 (-
C(O)O-CH2-CH2-), 57.09 (-CH2-N(CH3)2), 45.79 (-N(CH3)2), 44.73 (backbone quaternary), 
19.01 (backbone -CH2-), 18.78 (backbone -CH3). FTIR cm-1: 2944 (medium, C-H alkane), 
2820 and 2769 (medium, N-CH3 amine), 1722 (strong, C=O ester), 1455 (medium, C-H 
alkane), 1270-1265 (medium, C-N, amine), 1153 (strong, C-O ester). 
Synthesis of branched copolymer p(DMAEMA40-co-DMAEA10) 
For a typical polymerisation in which [DMAEMA]: [DMAEA]: [EGDMA]: [CTA]: [I] = 40: 
10: 1.5: 1: 0.05, CPAETC (21.06 mg, 0.0801 mmol), DMAEMA (0.503 g, 3.204 mmol), 
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DMAEA (0.115 g, 0.801 mmol), EGDMA (23.76 mg, 0.120 mmol), ACVA (1.12 mg, 0.0040 
mmol),  and dioxane (0.673 mL) were added to a vial deoxygenated by bubbling with nitrogen 
and left to stir in an oil bath at 70 °C. After a predetermined time, the solution was removed 
from the oil bath and the polymer precipitated in hexane (x3), and dried under vacuum. 
Mw,MALLS = 134,000 g/mol, Ð,RI = 3.1 (CHCl3 SEC, multi-detector). 
1H NMR spectrum (400 
MHz, CDCl3, δ ppm): 4.13 (m, 2H, -C(O)O-CH2-CH2-NMe2), 2.69 (m, 2H, -C(O)O-CH2-CH2-
NMe2), 2.29 (m, 6H, -CH2-NMe2), 2.18−0.77 (m, 5H, backbone). 13C NMR spectrum (100 
MHz, CDCl3, δ ppm): 177.31 (-C(O)O-), 63.02 (-C(O)O-CH2-CH2-), 57.07 (-CH2-N(CH3)2), 
45.78 (-N(CH3)2), 44.70 (backbone tertiary), 20.02 (backbone -CH2-), 18.02 (backbone -CH3). 
FTIR cm-1: 2944 (medium, C-H alkane), 2820 and 2769 (medium, N-CH3 amine), 1722 
(strong, C=O ester), 1455 (medium, C-H alkane), 1263-1270 (medium, C-N, amine), 1144 
(strong, C-O ester). 
Synthesis of branched copolymer p(DMAEMA10-co-DMAEA40) 
For a typical polymerisation in which [DMAEMA]: [DMAEA]: [DEGDA]: [CTA]: [I] = 10: 
40: 1.5: 1: 0.05, CPAETC (21.06 mg, 0.0801 mmol), DMAEMA (0.126 g, 0.801 mmol), 
DMAEA (0.458 g, 3.204 mmol), DEGDA (25.68 mg, 0.120 mmol), ACVA (1.12 mg, 0.0040 
mmol),  and dioxane (0.713 mL) were added to a vial deoxygenated by bubbling with nitrogen 
and left to stir in an oil bath at 70 °C. After a predetermined time, the solution was removed 
from the oil bath and the polymer precipitated in diethyl ether (x3), and dried under vacuum. 
Mw,MALLS = 66,600 g/mol, Ð,RI = 1.7 (CHCl3 SEC, multi-detector). 
1H NMR spectrum (400 
MHz, CDCl3, δ ppm): 4.17 (m, 2H, -C(O)O-CH2-CH2-NMe2), 2.65 (m, 2H, -C(O)O-CH2-CH2-
NMe2), 2.28 (m, 6H, -CH2-NMe2), 2.05−0.85 (m, 3H, backbone). 13C NMR spectrum (100 
MHz, CDCl3, δ ppm): 13C NMR spectrum (100 MHz, CDCl3, δ ppm): 174.26 (-C(O)O-), 62.35 
(-C(O)O-CH2-CH2-), 57.53 (-CH2-N(CH3)2), 45.72 (-N(CH3)2), 41.07 (backbone tertiary), 
25.02 (backbone -CH2-). FTIR cm-1: 2944 (medium, C-H alkane), 2820 and 2767 (medium, 
N-CH3 amine), 1726 (strong, C=O ester), 1455 (medium, C-H alkane), 1263 (medium, C-N, 
amine), 1155 (strong, C-O ester). 
 
DLS/Zetapotential 
Dynamic light scattering measurements of resulting polymers and polyplexes at various N/P 
ratios were carried out using a Malvern NanoZS Zetasizer instrument (scattering angle of 173°, 
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10 mW He-Ne laser). For polyplex formation: appropriate amount of polymer stock solution 
and DNA stock solution were mixed and made up to a total volume of 1 mL in DI water (final 
concentration of polymer was 1 mg/mL, in all solutions). The resulting solutions were vortexed 
incubated for 30 minutes at room temperature and were analysed at 25°C. Each sample was 
run in triplicate and data was acquired using the software provided (Malvern Zetasizer). Zeta 
potential measurements were carried out of the same DLS samples at various N/P ratios using 
the same instrument, and Malvern disposable folded capillary cell (DTS1070) cuvettes.  
Agarose gel electrophoresis 
Agarose gels (1% w/v) were prepared with agarose and 1 × TAE buffer with DNAse/RNAse 
free water. The solution was cooled on the bench for 5 minutes and 100 µL of 0.5 μg/mL 
ethidium bromide solution was added. The mixture was poured into the casted agarose tray and 
a comb inserted. The gel was left to set for a minimum of 30 minutes at room temperature. The 
agarose gels were run in 1× TAE buffer. The final gel was visualized under UV illumination 
at 365 nm using a UVP benchtop UV transilluminator system. Polyplexes of dsRNA were 
prepared at various N/P ratios. dsRNA stock solution of 60 µg/mL was prepared sterile water, 
and polymer stock solution of 300 µg/mL. For polyplex formation: appropriate amount of 
polymer stock solution and dsRNA stock solution were mixed and made up to a total volume 
of 100 µL (final concentration of dsRNA was 0.030 µg/µL, in all solutions). Polyplexes were 
vortexed and incubated at room temperature for 30 minutes. Prior to loading, 30 µL of loading 
buffer was added to each sample and 20 µL of polyplexes were loaded into the agarose gel 
wells. Gel electrophoresis was performed at 100 V for 20 minutes. 
Agarose gel dsRNA release study 
Polyplexes were formed in sterile water at an N/P ratio of 5 with a final concentration of 1 
mg/mL dsRNA. Samples were then divided into separate microtubes for each sample time 
point and stored at room temperature, until the microtubes were frozen at the appropriate time. 
When all the time points has been collected, samples were defrosted diluted to 100 µg/mL 
dsRNA. Prior to loading, loading buffer was added to each sample and 20 µL of polyplexes 
were loaded into the agarose gel wells. Gel electrophoresis was performed at 100 V for 20 
minutes on a 1% agarose gel containing ethidium bromide. 
Cell culture 
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NIH-3T3 mouse fibroblast cells were obtained from the Sigma-Aldrich and used between 
passages 5 and 15. Cells were grown in DMEM (Dulbecco's Modified Eagle Medium) 
supplemented with 10% of bovine calf serum, 1% of 2 mM glutamine and 1% 
penicillin/streptomycin. The cells were grown as adherent monolayers at 310 K under a 5% 
CO2 humidified atmosphere and passaged at approximately 70–80% confluence. 
In vitro toxicity assays  
NIH-3T3 mouse fibroblast cells were seeded in a 96 well plate at a density of 1 × 104 cells per 
well. After 16 hours, the culture medium was replaced by fresh media containing a series of 
dilution of the polymers. Following 24 hours incubation, the medium was removed and 
replaced with fresh medium. The cells were incubated with a freshly prepared solution of XTT 
(0.2 mg/mL) and N-methyl dibenzopyrazine methyl sulfate (250 µM) in medium for 16 hours. 
Absorbance of the samples was finally measured using a plate reader at 450 nm and 650 nm. 
The data presented are representative of a minimum of two independent experiments where 
each sample was measured in triplicate. Errors reported correspond to the standard deviation 
of the mean. For toxicity assays of polymers after two weeks hydrolysis, the polymers were 
incubated in sterile water (pH ~7.4) at concentrations of 8 mg/mL for two weeks. Before 
incubating with cells, hydrolysed polymer solution was diluted to the appropriate concentration 
in media. 
 
 
 
 
 
 
 
 
Results and Discussion 
 
Synthesis of highly branched polymers by RAFT 
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RAFT polymerisation was used to synthesise a series of highly branched polymers from a range 
of tertiary amine-containing vinyl monomers and divinyl branching comonomers (Scheme 1). 
Reaction temperature, initiator, chain transfer agent (CTA), and branching comonomer, were 
varied depending on monomer composition. Acrylate monomers (DMAEA, DMAPA and 
DEGDA) were polymerised at 70 ºC using PABTC as CTA, and ACVA as initiator. 
Methacrylate monomers (DMAEMA and EGDMA) were polymerised at 90 ºC using CPAETC 
as CTA, and VA088 as initiator. Copolymers of acrylate and methacrylate were polymerised 
at 70 ºC using CPAETC as CTA and ACVA as initiator. Either EGDMA or DEGDA was used 
as branching comonomer depending on the major proportion of monomer being acrylate or 
methacrylate. Having a branching monomer with similar reactivity as the main monomer feed 
increases its insertion into the backbone during the propagation step. Based on previous work, 
a degree of polymerisation (DP) of 50 with 0.95 – 2.5 molecules of branching monomer per 
CTA was targeted in order to form soluble highly branched polymers with similar and high 
molecular weights but without gelation.41 Linear equivalents of the branched 
DMAEMA/DMAEA copolymers were also synthesised, in order to identify any possible 
differences of polymer architecture on rate of hydrolysis. 
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Scheme 1. Synthesis of highly branched polymers (B1-B5) via RAFT polymerisation of tertiary amine- 
containing monomers (DMAEA, DMAPA, and DMAEMA) and divinyl branching monomers along with 
decomposition products from hydrolysis in aqueous/physiological conditions. 
 
SEC traces for the resulting branched polymers show a broad molecular weight distribution, as 
expected for branched polymerisation systems (Figure 1a). The molecular weights of the 
polymers were determined to be between 100,000 – 200,000 g/mol using light scattering 
detection SEC, as seen in Table 1. Information about the branched nature of the polymers was 
extracted from the intrinsic viscosity values measured by the viscometry detector. The Kuhn-
Mark-Houwink-Sakurada  values for each polymer were calculated from plotting the 
logarithmic intrinsic viscosity against the logarithmic molecular weight ( = gradient) (Figure 
1b). An   value between 0.6 and 0.8 corresponds to random coil in a good solvent whereas 
lower values indicates more dense structures close to the hard sphere model typically used for 
branched or star architectures. Table 1 shows the  values obtained for the synthesised 
polymers. For linear polymers  values fall between 0.6 – 0.8. The synthesised branched 
polymers had  values of between 0.36 – 0.53 as expected for more dense globular structures. 
1H NMR spectra of the purified polymers are shown in Figure 1c, however because of the 
branched nature of the polymers, and non-visible end groups, it was not possible to determine 
molecular weight values from the NMR spectra. 
 
Figure 1. a) Size-exclusion chromatograms (normalised DRI detector response vs retention time) for 
the branched polymers; b) Kuhn-Mark-Houwink-Sakurada (KMHS) plots of log intrinsic viscosity 
against log molecular weight from SEC viscosity detector in CHCl3 eluent; c) 
1H NMR spectra of 
tertiary amine containing highly branched polymers in deuterated chloroform. 
 
Table 1. Characterisation of branched and linear polymers prepared in this study, including 
compositions, molecular weights, dispersity, and Kuhn-Mark-Houwink-Sakurada alpha values. 
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Sample Structure 
M1 : M2 : 
M3 : B : 
CTA a 
Mn,SEC 
(g/mol) b 
Mw,SEC 
(g/mol) b 
Đ b 
Mw,MALLS 
(g/mol) c 
 d 
B1 p(DMAEA50-co-
DEGDA2.5) 
0 : 50 : 0 : 2.5 
: 1 
19,000 268,000 14 299,000 0.36 
B2 p(DMAPA50-co-
DEGDA2.5) 
0 : 0 : 50 : 2.5 
: 1 
22,000 168,000 7.6 193,000 0.53 
B3 p(DMAEMA10-co-
DMAEA40-co-
DEGDA1.5) 
10 : 40 : 0 : 
1.5 : 1 
18,100 31,100 1.7 66,600 0.53 
B4 p(DMAEMA40-co-
DMAEA10-co-
EGDMA1.5) 
40 : 10 : 0 : 
1.5 : 1 
17,600 54,900 3.1 134,000 0.42 
B5 p(DMAEMA50-co-
EGDMA0.95) 
50 : 0 : 0 : 
0.95 : 1 
27,000 218,000 8.2 275,000 0.41 
L1  p(DMAEMA10-co-
DMAEA40) 
10 : 40 : 0 : 0 : 1 7,300 9,000 1.24 8,200 0.56 
L2 p(DMAEMA40-co-
DMAEA10) 
40 : 10 : 0 : 0 : 1 7,100 9,800 1.37 8,400 0.61 
a  Ratio of monomer 1 (DMAEMA) to monomer 2 (DMAEA) to monomer 3 (DMAPA) to brancher (EGDMA or 
DEGDA) to CTA. b  From CHCl3 SEC, DRI detector, linear PS standard. c Molecular weight from light scattering 
detection on CHCl3 SEC.  d  = Kuhn-Mark-Houwink-Sakurada parameter, from CHCl3 SEC viscometry detector.  
 
Determination of DMAEMA and DMAEA reactivity ratios 
To better understand the copolymerisation of DMAEA and DMAEMA, the kinetics of their 
polymerisation was studied using 1H NMR spectroscopy. A statistical copolymer of DP 50 
containing 50% DMAEA and 50% DMAEMA was targeted (see polymerisation conditions in 
Supplementary Information). The conversion rate of each monomer, reported in Figure 2a, 
shows that the methacrylate is incorporated into the polymer faster than the acrylate. This trend, 
expected in the case of acrylate and methacrylate copolymerisations, could lead to slight 
gradient like nature of the polymer.42 For example, differences in monomer reactivity ratios in 
the copolymerisation of butyl acrylate and methyl methacrylate of rBA = 0.36 and rMMA = 
2.07 (rBA x rMMA = 0.75) lead to a copolymer with a higher proportion of MMA 
incorporation in the beginning of the polymerisation.43 
To further investigate the possible gradient-like nature of the copolymers of DMAEA and 
DMAEMA, the reactivity ratios of this comonomer system have been determined in typical 
RAFT conditions using three different calculation methods based on the same experimental 
data. For this purpose, a series of copoplymers containing 10%, 30%, 50%, 70%, and 90% of 
DMAEA were prepared. DP 50 was targeted and the polymerization were stopped at less than 
10% total monomer conversion. The reactivity ratios were then calculated using the Fineman 
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Ross method (rDMAEMA = 2.55 and rDMAEA = 0.93), the Kelen Tudos linearisation method 
(rDMAEMA = 2.29, rDMAEA = 0.71), and using a non-linear regression method based on a 
data fit of the copolymer equation (rDMAEMA = 2.13, rDMAEA = 0.69) (see Supporting 
Information). The last method, generalised by Van Herk in the 1990’s, is considered to be more 
accurate as it does not rely on linearisation of the data.44, 45 Figure 2b shows the plot of 
monomer incorporation ratio against monomer feed ratio and the non-linear regression fit of 
the data which gives values for the reactivity ratios. All three methods give values which are 
in good agreement, and indicate that DMAEMA has a tendency for self-propagation. The 
multiplication of reactivity ratios (rDMAEMA x rDMAEA = 1.47) indicates a slight gradient 
tendency in the polymerisation.46 However, we reason that when many chains (DP = 50) with 
slight monomer gradient are linked together in a statistical manner (as in the branched polymer 
synthesis), the effect of the gradient in the branched copolymers is greatly reduced. 
 
Figure 2. a) Monomer conversion against time for a statistical copolymer of DP = 50 containing 50 % 
DMAEA and 50 % DMAEMA, as determined by 1H NMR spectroscopy; b) Monomer incorporation 
ratio (F1) against monomer feed ratio (f1) (dots), including the non-linear regression fit of the data (red 
curve, giving rDMAEMA = 2.13, rDMAEA = 0.69), dashed line represents F1 = f1. 
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Polymer hydrolysis kinetic study 
The self-catalysed hydrolysis of pDMAEA in water was first reported in 1989, and was found 
to reach a limiting degree of hydrolysis of ~ 60 or 70 % after one week in aqueous conditions 
at room temperature.29 More recent studies have also found the hydrolysis to occur rapidly, and 
to be consistent with a self-catalysed mechanism at a rate that is independent of pH, salt 
concentration, or any other external stimulus.27, 30-32 The hydrolysis kinetics of the branched 
tertiary amine-containing polymers were studied using 1H NMR spectroscopy in D2O (pH ~ 
7.4). Figure 3a shows the 1H NMR spectra of branched p(DMAEMA10-co-DMAEA40) over a 
period of 20 days. 1H NMR spectra of hydrolysis study of remaining polymers can be found in 
the Supporting Information. The hydrolysis of DMAEA units in the polymer results in the 
appearance of sharp peaks at ~3.7 ppm, 2.9 ppm, and 2.6 ppm, due to the creation of 
dimethylaminoethanol hydrolysis product. Integration of these peaks in comparison with the 
peak at 4.2 ppm representing the total sum of monomer units was used to calculate the 
percentage hydrolysis. The resulting hydrolysis kinetic profiles are presented in Figure 3b. 
Branched pDMAEA hydrolyses relatively fast at first (40 % hydrolysed after 17 hours), then 
slows down to reach approximately 70 % hydrolysis after 20 days. As expected,38 the 
methacrylate polymer pDMAEMA does not shown any significant sign of hydrolysis after 20 
days. While branched p(DMAEMA10-co-DMAEA40) hydrolyses with a similar initial rate as 
pDMAEA homopolymer, the presence of 20% of methacrylate units resulted in an hydrolysis 
rate that is relatively similar to pDMAEA homopolymer in the first few hours, but which only 
reaches 50 % hydrolysis after 20 days. Branched pDMAPA reached a similar value of around 
50 % hydrolysis after 20 days, but with a slower initial gradient. Branched copolymer 
p(DMAEMA40-co-DMAEA10) showed very little hydrolysis and reaches a plateau of around 5 
% hydrolysis after 3 days. 
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Figure 3. a) Hydrolysis of branched p(DMAEMA10-co-DMAEA40) in D2O (pH ~7.4) as determined 
using 1H NMR spectroscopy; (other polymers shown in Supp. Info); b) Hydrolysis kinetics of synthesised 
branched and linear polymers in D2O (pH ~7.4) determined using 
1H NMR spectroscopy. 
 
We hypothesise that the hydrolysis of DMAEA in methacrylate /acrylate copolymers could be 
slowed by the more hydrophobic nature of the polymer backbone associated with the presence 
of methacrylate repeating units. This is exemplified by the copolymers containing 20% 
DMAEA (B4 and L2) proceeding to 5% hydrolysis instead of the expected value of around 15-
20%. 
It is worth noting that hydrolysis of 50% of the side chains of these polymers would result in 
zwitterionic polymers with an overall neutral charge, thus losing their ability to complex 
negatively charge dsRNA. Therefore, the two systems reaching 50% hydrolysis after a period 
of weeks, both p(DMAEMA10-co-DMAEA40) and pDMAPA, were thought to be promising 
candidates for slow dsRNA release. 
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Polyplex formation and dsRNA release 
Complexation of the branched polymers with dsRNA to form polyplexes was characterised by 
DLS and zetapotential measurements, as well as agarose gel electrophoresis. The later 
technique showed complete complexation of dsRNA by all the branched polymers for N/P 
ratios of either 1 or 2 (Figure S7). Therefore, an N/P ratio of 5 was chosen to characterise 
polyplex physiochemical properties in terms of size and surface charge (Table 2). 
 
Table 2. Size and surface charge (zetapotential) of polyplexes formed by complexation of dsRNA with 
polymers at N/P = 5, as measured by dynamic light scattering and electrophoretic light scattering. 
Polyplex (N/P 5) 
Zetapotential 
(mV) 
Size by 
number (nm) 
PDI 
B1 pDMAEA +15.1 ±1.4 488.9 ±87.1 0.53 
B2 pDMAPA +14.8 ±1.3 456.8 ±123.1 0.41 
B3 p(DMAEMA10-co-
DMAEA40) 
+15.3 ±1.5 448.4 ±65.3 0.85 
B4 p(DMAEMA40-co-
DMAEA10) 
+15.8 ±1.3 336.9 ±45.8 0.55 
B5 pDMAEMA +15.0 ±1.3 399.7 108.9 0.33 
L1 p(DMAEMA10-co-
DMAEA40) 
+14.3 ±1.3 541.1 ±100.6 0.58 
L2 p(DMAEMA40-co-
DMAEA10) 
+15.7 ±1.4 488.7 ±90.5 0.47 
 
All synthesised polymers appeared to form polyplexes with an overall positive charge of 
between 14 to 16 mV. Polyplex sizes were also found to be similar, with most polyplex 
diameters measured between 400 and 500 nm. The polydispersity values (Table 2) indicate a 
broad distribution of sizes for the polyplexes in solution. It is worth noting that this set of values 
represents a crude estimation of the real size of the polyplexes, as measurement by DLS is 
subject to significant error when assuming spherical shape.  
Next, an agarose gel electrophoresis experiment was designed to correlate polymer side chain 
hydrolysis and resulting charge reversal of the polymers to an observable release of dsRNA. 
Polyplexes were formed in sterile water at an N/P ratio of 5, and divided into separate 
microtubes for each sample time point, following which the samples were frozen at the 
appropriate time before being simultaneously analysed by agarose gel electrophoresis.  
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Pictures of the gels are shown in Figure 4. When the dsRNA is bound in a positively charged 
polyplex nanoparticle, the dsRNA band can be seen at the top of the gels in the well. Whereas 
negatively charged unbound dsRNA will move through the gel, resulting in a band at the 
bottom of the gel. It can be seen that all the synthesised polymers form strongly bound dsRNA 
polyplexes on day 0, apart from branched pDMAEA homopolymer which has already started 
to release the dsRNA over the course of sample preparation and/or gel preparation (Figure 4a). 
Both linear and branched p(DMAEMA10-co-DMAEA40) (Figures 4b and 4c respectively) start 
to release dsRNA after one day, and continue to release dsRNA over the course of more than 
14 days as the polymer slowly hydrolyses and the band corresponding to dsRNA moves down 
the gel towards the location of uncomplexed dsRNA. For these samples, complete dissociation 
from the dsRNA is observed after 21 days. Branched p(DMAPA) homopolymer showed a 
slower initial release (Figure 4d) with dsRNA remaining complexed for three days prior to 
releasing dsRNA. Full dissociation of dsRNA from the polymer was observed after 14 days. 
Both linear and branched p(DMAEMA40-co-DMAEA10) show no dsRNA release over the 
course of the study (Figure 4e and 4f), which is consistent with the very low percentage of 
hydrolysis for these polymers. Accordingly, branched pDMAEMA homopolymer, which does 
not undergo hydrolysis of the side chains, showed no dsRNA release.  
 
 
Figure 4. Agarose gel electrophoresis assay of branched cationic polymer – dsRNA polyplex 
nanoparticles (all at N/P ratio 5) over time periods up to 28 days; a) branched pDMAEA; b) linear 
p(DMAEMA10-co-DMAEA40); c) branched p(DMAEMA10-co-DMAEA40); d) branched pDMAPA; e) 
linear p(DMAEMA40-co-DMAEA10); f) branched p(DMAEMA40-co-DMAEA10); g) branched 
pDMAEMA. 
 
Overall, the results appear in accordance with the hydrolysis kinetic profiles of the polymers, 
and confirm the potential of the synthesised polymers for gene delivery applications. Branched 
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pDMAPA shows potential for delayed gene delivery applications, where release of 
oligonucleotides is required approximately one week after application. To the best of our 
knowledge, this study is the first to characterise the hydrolysis of pDMAPA and demonstrate 
its use for oligonucleotide complexation and controlled release. 
Copolymers of DMAEA and DMAEMA appear to be better suited for extended release of 
oligonucleotides, as they were shown to release dsRNA from day 1 to past day 14. We attribute 
this release profile to the presence of non-hydrolysable DMAEMA groups, which remain 
positively charged throughout the degradation process. These polymers show dsRNA release 
for over two weeks, which is a significant improvement over the pDMAEA and pDMAPA 
release profiles. Such sustained dsRNA release profiles would be useful for single injection 
gene silencing over periods of weeks.  
 
Polymer cytotoxicity 
The hydrolysis of cationic pDMAEA into biocompatible and non-cytotoxic poly(acrylic acid) 
(pAA) and N,N-dimethylamino ethanol (DMAE) is of benefit for use in biomedical 
appllications. PAA has been shown to be non-toxic to mammalian cell lines both in vitro and 
also in vivo,47, 48 while DMAE is approved and safely used in the cosmetics and the 
neutraceutical industries. Toxicity of synthesised polymers was investigated before and after 
hydrolysis against a model cell line, NIH-3T3 fibroblast. Branched polyethylenimine (bPEI), 
commonly used for gene delivery purposes, was also included as a positive control. Figure 5a 
shows the relative percentage of viable cells following 24 hours incubation with the polymers 
before hydrolysis. Branched pDMAEMA and p(DMAEMA40-co-DMAEA10) showed a 
toxicity profile similar to that of bPEI, with complete death of the cells at concentrations above 
50 g/mL. Branched pDMAPA and p(DMAEMA10-co-DMAEA40) showed a less toxic profile 
with zero cell survival at concentrations above 200 g/mL and 2 mg/mL, respectively. In 
contrast, the other polymers appeared to be relatively non-cytotoxic under the conditions tested. 
The trend of polymer toxicities appear to match the trend of hydrolysis profiles with the more 
hydrolysable polymers being less toxic. This can be attributed to the conversion of potentially 
toxic cationic polymers into biocompatible poly(acrylic acid) over the time of the experiment, 
or the increased membrane activity of the more hydrophobic methacrylate containing 
polymers. 
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Figure 5b shows the toxicity profiles determined for the same polymers but after a 2 week pre-
incubation in water at room temperature, following which polymers are expected to be almost 
completely hydrolysed. As expected, the non-hydrolysable polymers pDMAEMA and bPEI, 
have similar toxicity profiles to before incubation in water. The branched copolymer with 
majority DMAEMA monomer, p(DMAEMA40-co-DMAEA10), showed a slightly reduced 
toxicity compared to the non-hydrolysed version, which can be attributed to the hydrolysis of 
the small amount of DMAEA units. All other polymers tested showed no toxicity under the 
conditions studied, illustrating the conversion from toxic cationic polymer to non-toxic pAA. 
 
Figure 5. NIH-3T3 cell viability following 24 hr incubation in the presence of linear and branched 
polymers, as determined using XTT assay; a) initial polymers; b) polymers pre-incubated for 2 weeks 
in D2O at pH ~ 7.4. 
 
Conclusions 
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Highly branched polymers were synthesised with RAFT polymerisation of hydrolysable 
acrylate monomers containing tertiary amine functionality (DMAEA, DMAPA), non-
hydrolysable methacrylate counterpart (DMAEMA), and branching divinyl comonomers 
(EGDMA and DEGDA). The highly branched nature of these polymers was characterised 
using multi-detector SEC, and the copolymers were found to have a slightly gradient nature 
from calculation of the monomer reactivity ratios of the DMAEA and DMAEMA. Hydrolysis 
kinetics of the polymers were studied with 1H NMR spectroscopy, and showed pDMAPA and 
p(DMAEMA-co-DMAEA) to have hydrolysis profiles favourable for extended release of 
dsRNA compared to the fast hydrolysing pDMAEA. All the materials were shown to form 
polyplexes in presence of dsRNA and were characterized by DLS and agarose electrophoresis 
gels. The dsRNA release profiles of polyplex nanoparticles were also determined using agarose 
gel electrophoresis and both branched pDMAPA and p(DMAEMA10-co-DMAEA40) showed 
excellent prolonged release of oligonucleotide in aqueous conditions. Finally, the polymer 
cytotoxicity to NIH-3T3 fibroblast cell line was determined both before and after side chain 
hydrolysis. The most promising materials, pDMAPA and p(DMAEMA10-co-DMAEA40), 
show negligible toxicity in the appropriate concentration range (50 - 200 g/mL)  even before 
complete hydrolysis to biocompatible p(acrylic acid). Whereas non-hydrolysable branched 
pDMAEMA, bPEI, and also branched p(DMAEMA40-co-DMAEA10), had significant toxicity 
with zero cell proliferation above concentrations of 50 g/mL. These polymeric materials show 
great potential for therapeutic nucleic acid delivery as polyplexes, but could also represent an 
improved material for hydrogel formulations, nucleic acid releasing films, or other implantable 
or injestable polymeric constructs for controlled release. 
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